Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX™

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults[i]...
Pain / Anesthetics News From Medical News Today

Share:

Related Content